![Emil Chuang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emil Chuang
Director/Board Member at
PALISADE BIO, INC.
Net worth: 1 M $ as of 2026-07-30
Profile
Emil Chuang is currently an Independent Director at Palisade Bio, Inc. since 2025 and Chief Medical Officer at Intrinsic Medicine, Inc. since 2021.
Former roles include Global Head-Translational Research at Takeda Pharmaceutical Co., Ltd. from 2016 to 2018 and Vice President-Precision Medicine at Biora Therapeutics, Inc. from 2018 to 2020.
Education includes a doctorate from The University of Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PALISADE BIO, INC. 0.37% | 2026-06-09 | 612,500 ( 0.37% ) | 1 M $ | 2026-07-30 |
Emil Chuang active positions
| Companies | Position | Start |
|---|---|---|
| PALISADE BIO, INC. | Director/Board Member | 2025-07-06 |
Intrinsic Medicine, Inc.
 Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics used in leveraging human milk biology to create new medicines to transform gut-brain axis disorders | Chief Tech/Sci/R&D Officer | 2021-08-31 |
Former positions of Emil Chuang
| Companies | Position | End |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-11-30 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2018-05-31 |
Training of Emil Chuang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
45
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
Intrinsic Medicine, Inc.
Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics used in leveraging human milk biology to create new medicines to transform gut-brain axis disorders | Commercial Services |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
- Stock Market
- Insiders
- Emil Chuang
